Skip Navigation

Heather M Wilson-Robles

Associate Professor

Send Email

Phone: (979) 845-2351

Mailstop: 4474

Department: VSCS

Photo of Wilson-Robles, Heather

Education

  • Diplomate Oncology, ACVIM 2007
  • D.V.M. Veterinary Medicine, University of Tennessee 2003

Credentials

  • DVM, Diplomate ACVIM (Oncology)

Scholarly Interests

I have two main areas of scholarly interest. The first is bench top research focusing on identification and characterization of tumor initiating cells in solid tumors with a one health perspective (i.e. tumors similarities and treatment implications across species). The second focus of my research involves clinical trials in client owned dogs with spontaneously developing tumors as a basis for informing human clinical trials. Much of this research also has a one health implication designed to streamline drugs or therapies for human trials decreasing the cost of drug approval while improving therapeutic options for canines afflicted with cancer.

Publications

Identification and evaluation of putative tumour-initiating cells in canine malignant melanoma cell lines(†).
Wilson-Robles HM, Daly M, Pfent C, Sheppard S.
Vet Comp Oncol. 2013 Feb; .
PMID: 23410087 [PubMed - as supplied by publisher]
Aryl hydrocarbon receptor agonists induce microRNA-335 expression and inhibit lung metastasis of estrogen receptor negative breast cancer cells.
Zhang S, Kim K, Jin UH, Pfent C, Cao H, Amendt B, Liu X, Wilson-Robles H, Safe S.
Mol Cancer Ther. 2012 Jan; 11(1):108-18.
PMID: 22034498 [PubMed - indexed for MEDLINE]
Effect of tolfenamic acid on canine cancer cell proliferation, specificity protein (sp) transcription factors, and sp-regulated proteins in canine osteosarcoma, mammary carcinoma, and melanoma cells.
Wilson H, Chadalapaka G, Jutooru I, Sheppard S, Pfent C, Safe S.
J Vet Intern Med. 2012 Jul; 26(4):977-86.
PMID: 22536857 [PubMed - indexed for MEDLINE]
Subcutaneous infection of a cat by Colletotrichum species.
Winter RL, Lawhon SD, Halbert ND, Levine GJ, Wilson HM, Daly MK..
J Fel Med and Surg. 2010 Oct; 12(10):828-30.
PMID: 20813572 []
Feline alimentary lymphoma: demystifying the enigma.
Wilson HM.
Top Companion Anim Med. 2008 Nov; 23(4):177-84.
PMID: 19081551 [PubMed - indexed for MEDLINE]
Isolation and characterisation of cancer stem cells from canine osteosarcoma.
Wilson H, Huelsmeyer M, Chun R, Young KM, Friedrichs K, Argyle DJ.
Vet J. 2008 Jan; 175(1):69-75.
PMID: 17851099 [PubMed - indexed for MEDLINE]
Is cancer a stem cell disease? Theory, evidence and implications.
Blacking TM, Wilson H, Argyle DJ.
Vet Comp Oncol. 2007 Jun; 5(2):76-89.
PMID: 19754791 [PubMed]
Clinical signs, treatments, and outcome in cats with transitional cell carcinoma of the urinary bladder: 20 cases (1990-2004).
Wilson HM, Chun R, Larson VS, Kurzman ID, Vail DM.
J Am Vet Med Assoc. 2007 Jul; 231(1):101-6.
PMID: 17605672 [PubMed - indexed for MEDLINE]
Predictors of outcome in dogs with subcutaneous or intramuscular hemangiosarcoma.
Shiu KB, Flory AB, Anderson CL, Wypij J, Saba C, Wilson H, Kurzman I, Chun R..
J AM VEt MEd Assoc. 2011 Feb; 15;238(4):472-9..
PMID: 21320017 []
Adoptive T-cell therapy improves treatment of canine non-Hodgkin lymphoma post chemotherapy.
O'Connor CM, Sheppard S, Hartline CA, Huls H, Johnson M, Palla SL, Maiti S, Ma W, Davis RE, Craig S, Lee DA, Champlin R, Wilson H, Cooper LJ..
Sci Rep. ; .
PMID: 22355761 []